(34.231.21.105)
Users online: 1332    [ij] [ij] [ij] 
Email id
 

RESEARCH JOURNAL OF PHARMACEUTICAL DOSAGE FORMS AND TECHNOLOGY
Year : 2020, Volume : 12, Issue : 4
First page : ( 295) Last page : ( 297)
Print ISSN : 0975-234X. Online ISSN : 0975-4377.
Article DOI : 10.5958/0975-4377.2020.00048.8

A review on zika virus infection

Yadav Akshay R.*, Mohite Shrinivas K.

Department of Pharmaceutical Chemistry, Rajarambapu College of Pharmacy, Kasegaon, Sangli, Maharashtra, India-415404.

*Corresponding Author E-mail: akshayyadav24197@gmail.com

Online published on 10 February, 2021.

Abstract

In Uganda, in 1947, Zika virus was initially identified in monkeys through a method that detected yellow fever. It was subsequently distinguished among the people of Uganda and Tanzania in 1952. Zika infection has reported the primary substantial outbreak of disease from Island of Yap.Brazil describes a partnership between the Zika virus infection and Guillain-Barre disorder in the month of July 2015. In this review we discuss various basic and clinical aspects of infection with Zika virus including virology, epidemiology and disease pathogenesis. Laboratory methods required for disease diagnosis along with ethical issues associated with Zika virus infection will be discussed in detail as well. Zika virus disease is typically mild and needs no treatment. There is actually no vaccine for Zika Virus disease.

Top

Keywords

Zika virus, Guillain-Barre disorder, Flavivirus, Molecular assays.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
596,791,026 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.